Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
125.83
+0.10 (0.08%)
At close: Jul 23, 2025, 4:00 PM
125.61
-0.22 (-0.17%)
After-hours: Jul 23, 2025, 7:50 PM EDT

Abbott Laboratories Revenue by Segment

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Medical Devices
19.43B18.99B18.38B17.88B17.44B16.89B16.19B15.56B
Medical Devices Growth
11.40%12.43%13.48%14.90%16.10%14.98%10.27%5.83%
Diagnostics
9.18B9.34B9.36B9.39B9.51B9.99B10.76B11.98B
Diagnostics Growth
-3.50%-6.48%-13.05%-21.61%-31.97%-39.77%-39.39%-33.41%
Nutrition
8.49B8.41B8.32B8.33B8.26B8.15B7.93B7.66B
Nutrition Growth
2.86%3.18%4.90%8.80%9.60%9.32%3.24%-4.28%
Established Pharmaceuticals
5.23B5.19B5.15B5.11B5.10B5.07B5.06B5.02B
Established Pharmaceuticals Growth
2.45%2.53%1.74%1.83%3.01%3.14%3.29%3.72%
Other
16.00M16.00M15.00M15.00M14.00M14.00M13.00M12.00M
Other Growth
14.29%14.29%15.38%25.00%27.27%27.27%18.18%-36.84%

Revenue by Geography

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
International
25.70B25.63B25.29B25.18B24.96B24.66B24.24B24.23B
International Growth
2.98%3.93%4.33%3.93%2.40%-3.35%-7.68%-8.56%
United States
16.65B16.32B15.93B15.55B15.37B15.45B15.72B16.00B
United States Growth
8.30%5.64%1.33%-2.83%-10.29%-14.83%-16.27%-16.02%

Operating Expense Breakdown

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Selling, General, and Administrative
11.80B11.70B11.51B11.34B11.15B10.95B11.20B11.21B
Selling, General, and Administrative Growth
5.86%6.83%2.82%1.21%-0.69%-2.66%-1.10%-1.35%
Research and Development
2.88B2.84B2.80B2.75B2.77B2.74B2.77B2.88B
Research and Development Growth
3.79%3.76%1.05%-4.24%-2.60%-5.09%-5.44%2.17%
Amortization
1.83B1.88B1.89B1.92B1.95B1.97B1.98B1.98B
Amortization Growth
-6.21%-4.48%-4.39%-3.18%-2.26%-2.33%-2.46%-3.41%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.